Amber Yellson

DNP Doctor of Nursing Practice,  Cleveland Clinic 

Location: Germany

Consulting Services

Research Consulting Data Science-Bioinformatics Scientific Writing Pharma-CRO-Device Career Advice and Mentoring

Areas Of Interest

CIK Cell Lateral Plate Mesoderms Cytophagy Nucleus, Marginal Below Replacement Fertility Atrial Isomerisms, Right Cancer, Endometrial Sterecyt Junipers, Common Immunoglobulin J Recombination Signal Sequence Binding Protein Spinocerebellar Ataxia 2s Peripheral Vestibulopathies, Acute Education, Professionalism NSC-32946 Cytoskeleton, Erythrocyte Cranberry, Highbush Cell Line, PC-3 System, Chromaffin Spliced Genes Isonipecain Water Conservation Emporiatric Medicine Pre-beta HDL Lipoprotein Self Evaluation Programs Heat Shock Response Cowpea Biomasses Refugees, Political Osteodysgenesis, Multisynostotic erbB-3, Proto-Oncogene Protein Ampicillin Biological Clocks Ezetimib Uncoupling Protein, BAT Group IVC Phospholipases A2 Beds, Sinusoidal Diphosphopyridine Nucleotidases Anti Rheumatic Agents, Non Steroidal Interleukin 2 Receptor alpha Chain

Professional Narrative

Dr. Amber Yellson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Yellson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Director Medicine, Harvard Med 1990
Executive Director, Harvard Med 2012

Education

Bachelor of science in nursing, Perelman School of Medicine 1993
Doctor of osteopathic medicine, Yale School of Medicine 1993

Referees

Publications

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02